CA2026384A1 - A solid drug form with a high verapamil content - Google Patents

A solid drug form with a high verapamil content

Info

Publication number
CA2026384A1
CA2026384A1 CA002026384A CA2026384A CA2026384A1 CA 2026384 A1 CA2026384 A1 CA 2026384A1 CA 002026384 A CA002026384 A CA 002026384A CA 2026384 A CA2026384 A CA 2026384A CA 2026384 A1 CA2026384 A1 CA 2026384A1
Authority
CA
Canada
Prior art keywords
solid drug
drug form
verapamil
content
granulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002026384A
Other languages
French (fr)
Other versions
CA2026384C (en
Inventor
Helmut Fricke
Thomas Moest
Ernst Flaig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2026384A1 publication Critical patent/CA2026384A1/en
Application granted granted Critical
Publication of CA2026384C publication Critical patent/CA2026384C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A solid drug form containing net less than 90 % by weight verapamil is produced by granulating at from 30 to 55°C with a little water, drying and, where appropriate, conventional tableting or by pelleting, in which case the granules obtained as described are, after cooling, moistened once again and compacted in a granulating mixer at from 30 to 55°C and are dried.
CA002026384A 1989-09-28 1990-09-27 A solid drug form with a high verapamil content Expired - Fee Related CA2026384C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3932378.1 1989-09-28
DE3932378A DE3932378A1 (en) 1989-09-28 1989-09-28 SOLID MEDICAL FORM WITH A HIGH VERAPAMIL CONTENT

Publications (2)

Publication Number Publication Date
CA2026384A1 true CA2026384A1 (en) 1991-03-29
CA2026384C CA2026384C (en) 2002-04-09

Family

ID=6390380

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002026384A Expired - Fee Related CA2026384C (en) 1989-09-28 1990-09-27 A solid drug form with a high verapamil content

Country Status (8)

Country Link
EP (1) EP0420042B1 (en)
JP (1) JP3100615B2 (en)
AT (1) ATE78159T1 (en)
CA (1) CA2026384C (en)
DE (2) DE3932378A1 (en)
DK (1) DK0420042T3 (en)
ES (1) ES2043210T3 (en)
GR (1) GR3005754T3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534262A (en) * 1992-01-10 1996-07-09 Dobrotvorsky; Anatoly E. Pharmaceutical granulated composition and method for preparing same
RU2145214C1 (en) * 1999-07-08 2000-02-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Pharmaceutical composition exhibiting cardiovascular effect

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3113901A1 (en) * 1981-04-07 1982-10-28 Basf Ag, 6700 Ludwigshafen ACTIVE SUBSTANCE PREPARATION FOR ORAL APPLICATION
LU86099A1 (en) * 1985-09-30 1987-04-02 Pharlyse EXTENDED RELEASE GALENIC FORMS OF VERAPAMIL, THEIR MANUFACTURE AND THE MEDICINAL PRODUCTS CONTAINING THEM
JP2804048B2 (en) * 1987-09-11 1998-09-24 イー・アール・スクイブ・アンド・サンズ・インコーポレイテッド High drug content pharmaceutical composition and method for producing the same

Also Published As

Publication number Publication date
DE59000209D1 (en) 1992-08-20
EP0420042B1 (en) 1992-07-15
CA2026384C (en) 2002-04-09
ES2043210T3 (en) 1993-12-16
EP0420042A2 (en) 1991-04-03
GR3005754T3 (en) 1993-06-07
EP0420042A3 (en) 1991-04-24
ATE78159T1 (en) 1992-08-15
DK0420042T3 (en) 1992-10-05
JP3100615B2 (en) 2000-10-16
DE3932378A1 (en) 1991-04-11
JPH03167122A (en) 1991-07-19

Similar Documents

Publication Publication Date Title
HUT65527A (en) Process for production of tablets, granulates and pellets with high drug contents
ES8500739A1 (en) Extended action controlled release compositions.
JPS56144055A (en) Tablet confectionery containing bifidus bacterium and its production
KR910014120A (en) Oral Pharmaceutical Formulations of Fimovevenan
CA2208441A1 (en) Animal excrement treating material and method of manufacturing same
CA2026384A1 (en) A solid drug form with a high verapamil content
FR2787811B1 (en) POWDER DEXTROSE AND PROCESS FOR THE PREPARATION THEREOF
JPS5299217A (en) Vermin attractants
JPS5315425A (en) Blend-type resticide granules
EP0181153A3 (en) Process for the utilisation of solid paper mill waste
RU96113711A (en) METHOD FOR PREPARING PEAT FOR BRIQUETTING
JPS55165144A (en) Deodorant
JPS53118526A (en) Preparation of granular pesticide for agricultural and horticultural use
JPS57125666A (en) Storing method of raw rice flour
JPS57204227A (en) Uranium adsorbing material molded into fibrous form
TH13475A (en) Pharmaceutical formulas
JPS5721315A (en) Stable solid preparation of cytochrome c and its preparation
JPS5594315A (en) Antibacterial drug
Lohoar et al. Production and marketing handbook for horticultural crops in Barbados
JPS52125118A (en) Manufacture of sorbic acid granules
JPS56106563A (en) Granulated gum guaiac and its preparation
JPS5237262A (en) Movable drier for pastures and other grasses
Novikov A Theoretical Analysis of the Structure of the Ionic Subsystem of Sn sub 30 Au sub 70 and Sn sub 90 Au sub 10 Alloys in the Liquid and Solid Amorphous States
RU98118896A (en) MEDICAL-PROPHYLACTIC MEDICINE
JPS52128351A (en) Preparation of alpha-elemene and delta-elemene

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed